http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2138875-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bee8b2c674d7ec672688001f27aa95fe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-86
filingDate 1972-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1973-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2138875-A1
titleOfInvention Substd aminoalkanoylamino (thi)xanthones and acridones - - with psychotherapeutic and/or sedative activity
abstract Cpds. of formula (I): (where R1 is H, Me, MeO, CF3, Cl, F, NO2 acetyl, or MeS, R2 and R3 are H or alkyl; X is O, S, SO, SO2, NH or N-alkyl; Y is (di)alkylamino, >=2C hydroxyalkylamino, di(>=2C hydroxyalkyl)-amino, dialkylamino-alkylamino, cycloalkylamino, piperidino, morpholino piperazino, N-alkylpiperazino, N-(>=2C hydroxyalkyl) piperazino, adamantylamino, arylamino or diarylamino both opt. substd. by halogen or alkoxy) and their salts are prepd. by methods known for analogous cpds. e.g. reaction of (I; Y = Cl, Br or I) with an amine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6797841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6140385-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9744364-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6781015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6762323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479706-B1
priorityDate 1971-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550218

Total number of triples: 20.